Analytical Data
-
基因名
KAZALD1
- Application
-
别名
KAZALD1；Kazal-type serine protease inhibitor domain-containing Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96I82
-
表达区间
31-304aa
-
氨基酸序列
RPSPGPDYLR RGWMRLLAEG EGCAPCRPEE CAAPRGCLAG RVRDACGCCW ECANLEGQLC DLDPSAHFYG HCGEQLECRL DTGGDLSRGE VPEPLCACRS QSPLCGSDGH TYSQICRLQE AARARPDANL TVAHPGPCES GPQIVSHPYD TWNVTGQDVI FGCEVFAYPM ASIEWRKDGL DIQLPGDDPH ISVQFRGGPQ RFEVTGWLQI QAVRPSDEGT YRCLGRNALG QVEAPASLTV LTPDQLNSTG IPQLRSLNLV PEEEAESEEN DDYY
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KAZALD1, a member of the Kazal-type serine protease inhibitor family, has garnered attention due to its potential role in various biological processes and its implications in disease states. Studies have indicated that KAZALD1 is involved in regulating inflammatory responses, wound healing, and other key physiological functions. Its expression patterns suggest that it plays a significant role in tissue remodeling and repair mechanisms. Recent research has focused on the recombinant expression and purification of KAZALD1 to better understand its structure-function relationships and inhibitory mechanisms against serine proteases. By producing KAZALD1 as a recombinant protein, researchers aim to elucidate its interactions with specific proteases and explore its therapeutic potential in conditions such as cancer, autoimmune diseases, and chronic inflammatory disorders. The recombinant KAZALD1 protein serves as a valuable tool for both in vitro and in vivo studies, paving the way for deeper insights into its biological roles and potential applications in drug development and disease management. The growing interest in KAZALD1 emphasizes the need for continued research into its functional properties and regulatory mechanisms, which may ultimately lead to novel therapeutic strategies targeting serine protease-related pathways.
